A fraud of this magnitude? It will affect all of the most recent DNA based methodology applications, certainly those companies who import the Chinese garbage. Also, it will allow the FDA to continue to slow boat all of the antigen/antibody methodologies. But the DECN application will probably slip through. Designed in America is a big deal.